Passage Bio, Inc.
PASG
$4.59
$0.020.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 41.78% | -67.54% | 17.43% | 39.08% | -21.06% |
| Total Depreciation and Amortization | -27.12% | -2.21% | 7.10% | -15.92% | -72.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.87% | 573.81% | -34.79% | -74.14% | 310.88% |
| Change in Net Operating Assets | -347.96% | 5.04% | 7.95% | 185.97% | -184.59% |
| Cash from Operations | -100.45% | -33.51% | 23.33% | 54.29% | -63.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 0.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 185.17% |
| Cash from Investing | -- | -- | -100.00% | -98.52% | 189.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.42% | -33.32% | 15.32% | -122.23% | 388.24% |